The use of AI in biotechnology is changing faster than the rules governing either technology
Some lower- risk gene-editing technologies would be exempt from regulation, while activities deemed to pose greater risks would remain subject to ...
Read the original at The Conversation ↗
- Topics
- Regulation & Policy
- Tracked via
- “AI Risks”